Renal allograft recipients fail to increase interferon-γ during invasive fungal diseases

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3437-3440

  Armstrong James, D ^a   Teo, I ^a   Herbst, S ^a   Petrou, M ^a   Shiu, K Y ^b   McLean, A ^c   Taube, D ^c   Dorling, A ^b   Shaunak, S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Cytokines; diagnosis; interferon ; invasive fungal disease; renal allograft

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GRAFT RECIPIENT; IMMUNE RESPONSE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC MYCOSIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870517077     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04254.x     Document Type: Article

References (20)

1. Pappas PG, Alexander BD, Andes DR, et al,. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-1111.
2. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, Roberts JP,. Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant 2008; 8: 745-752.
3. Baddley JW, Andes DR, Marr KA, et al,. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559-1567.
4. Armstrong-James DP, Turnbull SA, Teo I, et al,. Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis. J Infect Dis 2009; 200: 1341-1351.
5. Armstrong-James D, Teo IA, Shrivastava S, et al,. Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients. Am J Transplant 2010; 10: 1796-1803.
6. Halloran PF, Afrouzian M, Ramassar V, et al,. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol 2001; 158: 215-226.
7. De Pauw B, Walsh TJ, Donnelly JP, et al,. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
8. Corware K, Harris D, Teo I, et al,. Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid. Biomaterials 2011; 32: 8029-8039.
9. Shaunak S, Thomas S, Gianasi E, et al,. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol 2004; 22: 977-984.
10. Romani L,. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1-23.
11. Kino T, Hatanaka H, Miyata S, et al,. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987; 40: 1256-1265.
12. Greenblatt MB, Aliprantis A, Hu B, Glimcher LH,. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 2010; 207: 923-931.
13. Bhatia S, Fei M, Yarlagadda M, et al,. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One 2011; 6: e15943.
14. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
15. Jiang X, Kojo S, Harada M, Ohkohchi N, Taniguchi M, Seino KI,. Mechanism of NKT cell-mediated transplant tolerance. Am J Transplant 2007; 7: 1482-1490.
16. Mittal SK, Sharma RK, Gupta A, Naik S,. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. Transplantation 2009; 88: 435-441.
17. Steinke JW, Barekzi E, Hagman J, Borish L,. Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J Immunol 2004; 173: 3215-3222.
18. Seo KW, Kim DH, Sohn SK, et al,. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1089-1095.
19. Sambatakou H, Pravica V, Hutchinson IV, Denning DW,. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006; 33: 297-302.
20. Teo I, Toms SM, Marteyn B, et al., Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers. EMBO Mol Med 2012; 4: 866-881.